Literature DB >> 12915583

Protective efficacy of an AIDS vaccine, a single DNA priming followed by a single booster with a recombinant replication-defective Sendai virus vector, in a macaque AIDS model.

Akiko Takeda1, Hiroko Igarashi, Hiromi Nakamura, Munehide Kano, Akihiro Iida, Takahiro Hirata, Mamoru Hasegawa, Yoshiyuki Nagai, Tetsuro Matano.   

Abstract

We previously demonstrated the excellent protective efficacy of DNA priming followed by Gag-expressing Sendai virus (SeV) boosting (DNA prime/SeV-Gag boost vaccine) against a pathogenic simian-human immunodeficiency virus (SHIV89.6PD) infection in macaques. Here we show that we established a practical, safer AIDS vaccine protocol, a single DNA priming followed by a single booster with a recently developed replication-defective F deletion SeV-expressing Gag, and show its protective efficacy against SHIV89.6PD infections.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12915583      PMCID： PMC187428          DOI： 10.1128/jvi.77.17.9710-9715.2003

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  26 in total

Review 1.  T lymphocyte responses in HIV-1 infection: implications for vaccine development.

Authors:  C Brander; B D Walker
Journal:  Curr Opin Immunol       Date:  1999-08       Impact factor: 7.486

Review 2.  Paramyxovirus replication and pathogenesis. Reverse genetics transforms understanding.

Authors:  Y Nagai
Journal:  Rev Med Virol       Date:  1999 Apr-Jun       Impact factor: 6.989

3.  Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes.

Authors:  J E Schmitz; M J Kuroda; S Santra; V G Sasseville; M A Simon; M A Lifton; P Racz; K Tenner-Racz; M Dalesandro; B J Scallon; J Ghrayeb; M A Forman; D C Montefiori; E P Rieber; N L Letvin; K A Reimann
Journal:  Science       Date:  1999-02-05       Impact factor: 47.728

4.  Infection and pathogenicity of chimeric simian-human immunodeficiency viruses in macaques: determinants of high virus loads and CD4 cell killing.

Authors:  R Shibata; F Maldarelli; C Siemon; T Matano; M Parta; G Miller; T Fredrickson; M A Martin
Journal:  J Infect Dis       Date:  1997-08       Impact factor: 5.226

5.  Rhesus macaques that become systemically infected with pathogenic SHIV 89.6-PD after intravenous, rectal, or vaginal inoculation and fail to make an antiviral antibody response rapidly develop AIDS.

Authors:  Y Lu; C D Pauza; X Lu; D C Montefiori; C J Miller
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1998-09-01

6.  Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA.

Authors:  G S Ogg; X Jin; S Bonhoeffer; P R Dunbar; M A Nowak; S Monard; J P Segal; Y Cao; S L Rowland-Jones; V Cerundolo; A Hurley; M Markowitz; D D Ho; D F Nixon; A J McMichael
Journal:  Science       Date:  1998-03-27       Impact factor: 47.728

7.  A cytoplasmic RNA vector derived from nontransmissible Sendai virus with efficient gene transfer and expression.

Authors:  H O Li; Y F Zhu; M Asakawa; H Kuma; T Hirata; Y Ueda; Y S Lee; M Fukumura; A Iida; A Kato; Y Nagai; M Hasegawa
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

8.  Induction of protective immunity against pathogenic simian immunodeficiency virus by a foreign receptor-dependent replication of an engineered avirulent virus.

Authors:  T Matano; M Kano; T Odawara; H Nakamura; A Takeda; K Mori; T Sato; Y Nagai
Journal:  Vaccine       Date:  2000-08-01       Impact factor: 3.641

9.  Rapid effector function in CD8+ memory T cells.

Authors:  A Lalvani; R Brookes; S Hambleton; W J Britton; A V Hill; A J McMichael
Journal:  J Exp Med       Date:  1997-09-15       Impact factor: 14.307

10.  Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques.

Authors:  X Jin; D E Bauer; S E Tuttleton; S Lewin; A Gettie; J Blanchard; C E Irwin; J T Safrit; J Mittler; L Weinberger; L G Kostrikis; L Zhang; A S Perelson; D D Ho
Journal:  J Exp Med       Date:  1999-03-15       Impact factor: 14.307
View more
  17 in total

1.  Involvement of multiple epitope-specific cytotoxic T-lymphocyte responses in vaccine-based control of simian immunodeficiency virus replication in rhesus macaques.

Authors:  Miki Kawada; Hiroko Igarashi; Akiko Takeda; Tetsuo Tsukamoto; Hiroyuki Yamamoto; Sachi Dohki; Masafumi Takiguchi; Tetsuro Matano
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

2.  Long-term control of simian immunodeficiency virus replication with central memory CD4+ T-cell preservation after nonsterile protection by a cytotoxic T-lymphocyte-based vaccine.

Authors:  Miki Kawada; Tetsuo Tsukamoto; Hiroyuki Yamamoto; Akiko Takeda; Hiroko Igarashi; David I Watkins; Tetsuro Matano
Journal:  J Virol       Date:  2007-03-07       Impact factor: 5.103

3.  Control of simian immunodeficiency virus replication by vaccine-induced Gag- and Vif-specific CD8+ T cells.

Authors:  Nami Iwamoto; Naofumi Takahashi; Sayuri Seki; Takushi Nomura; Hiroyuki Yamamoto; Makoto Inoue; Tsugumine Shu; Taeko K Naruse; Akinori Kimura; Tetsuro Matano
Journal:  J Virol       Date:  2013-10-23       Impact factor: 5.103

4.  Vaccine-induced CD107a+ CD4+ T cells are resistant to depletion following AIDS virus infection.

Authors:  Kazutaka Terahara; Hiroshi Ishii; Takushi Nomura; Naofumi Takahashi; Akiko Takeda; Teiichiro Shiino; Yasuko Tsunetsugu-Yokota; Tetsuro Matano
Journal:  J Virol       Date:  2014-10-01       Impact factor: 5.103

Review 5.  Non-human primate models for AIDS vaccine research.

Authors:  Shiu-Lok Hu
Journal:  Curr Drug Targets Infect Disord       Date:  2005-06

6.  Gag-specific cytotoxic T-lymphocyte-based control of primary simian immunodeficiency virus replication in a vaccine trial.

Authors:  Miki Kawada; Tetsuo Tsukamoto; Hiroyuki Yamamoto; Nami Iwamoto; Kyoko Kurihara; Akiko Takeda; Chikaya Moriya; Hiroaki Takeuchi; Hirofumi Akari; Tetsuro Matano
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

7.  Induction of CD8+ cells able to suppress CCR5-tropic simian immunodeficiency virus SIVmac239 replication by controlled infection of CXCR4-tropic simian-human immunodeficiency virus in vaccinated rhesus macaques.

Authors:  Tetsuo Tsukamoto; Mitsuhiro Yuasa; Hiroyuki Yamamoto; Miki Kawada; Akiko Takeda; Hiroko Igarashi; Tetsuro Matano
Journal:  J Virol       Date:  2007-08-29       Impact factor: 5.103

8.  Mycobacterium tuberculosis culture filtrate proteins plus CpG Oligodeoxynucleotides confer protection to Mycobacterium bovis BCG-primed mice by inhibiting interleukin-4 secretion.

Authors:  Denise Morais da Fonseca; Celio Lopes Silva; Pryscilla Fanini Wowk; Marina Oliveira E Paula; Simone Gusmão Ramos; Cynthia Horn; Gilles Marchal; Vânia Luiza Deperon Bonato
Journal:  Infect Immun       Date:  2009-09-14       Impact factor: 3.441

9.  A novel protective MHC-I haplotype not associated with dominant Gag-specific CD8+ T-cell responses in SIVmac239 infection of Burmese rhesus macaques.

Authors:  Naofumi Takahashi; Takushi Nomura; Yusuke Takahara; Hiroyuki Yamamoto; Teiichiro Shiino; Akiko Takeda; Makoto Inoue; Akihiro Iida; Hiroto Hara; Tsugumine Shu; Mamoru Hasegawa; Hiromi Sakawaki; Tomoyuki Miura; Tatsuhiko Igarashi; Yoshio Koyanagi; Taeko K Naruse; Akinori Kimura; Tetsuro Matano
Journal:  PLoS One       Date:  2013-01-14       Impact factor: 3.240

10.  Cytotoxic T lymphocyte-based control of simian immunodeficiency virus replication in a preclinical AIDS vaccine trial.

Authors:  Tetsuro Matano; Masahiro Kobayashi; Hiroko Igarashi; Akiko Takeda; Hiromi Nakamura; Munehide Kano; Chie Sugimoto; Kazuyasu Mori; Akihiro Iida; Takahiro Hirata; Mamoru Hasegawa; Takae Yuasa; Masaaki Miyazawa; Yumiko Takahashi; Michio Yasunami; Akinori Kimura; David H O'Connor; David I Watkins; Yoshiyuki Nagai
Journal:  J Exp Med       Date:  2004-06-21       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.